TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
$839,875,190
| Recipient | AMGEN USA INC UEI XPGNQMXHP493 |
|---|---|
| Award ID | 75A50122C00065 |
| Award amount | $839,875,190 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Set-aside | Unrestricted |
| Start date | Sep 30, 2022 |
| End date | Sep 29, 2032 |
| Place of performance | NEWBURY PARK, CA |
| Record updated | Aug 4, 2026 |
View the official award record
More awards won by AMGEN USA INC
IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION
Department of Health and Human Services · $154,444,070 · Sep 13, 2018
VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.
Department of Health and Human Services · $854,020 · Mar 12, 2024
RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION
Department of Health and Human Services · $657,406 · Sep 19, 2018
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids